CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Bupivacaine Placebo +3 moredrug
Likely dose
Bupivacaine Placebo 20mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01015807
NCT01015807N/ACompleted
CompareCT.gov

Transversus Abdominis Plane (TAP) Block for Cesarean Section

University of Washington·interventional·Posted Nov 18, 2009·Updated Oct 23, 2017

In Brief

A clinical study evaluating Bupivacaine Placebo, Clonidine Placebo, and 2 other interventions for Hyperalgesia, Secondary. Completed, enrolled 90 participants across 2 sites in 2 countries.

Detailed Summary

The purpose of this study is to determine whether a transversus abdominis plane (TAP) block with Clonidine added to the injectate (Clo-TAP) performed approximately 2hrs after the cesarean section (CS) will decrease the amount of postoperative hyperalgesia and ultimately reduce post-CS chronic pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperalgesia, Secondary
CountriesBrazil, United States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 18, 2009
Enrollment StartNov 1, 2009
Primary CompletionAug 1, 2010
Study CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 16.6 years ago

Interventions

Bupivacaine Placebodrug

2 x 20mL 0.9% NaCl

Clonidine Placebodrug

2 x 1mL 0.9% NaCl

Bupivacainedrug

2 x 20mL 0.375% Bupivacaine = 150 mg Bupivacaine

Clonidinedrug

2 x 1ml Clonidine = 150 µg Clonidine